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Friedreich ataxia is considered a neurodegenerative disorder involving both the peripheral
and central nervous systems. Dorsal root ganglia (DRG) are the major target tissue
structures.This neuropathy is caused by mutations in the FXN gene that encodes frataxin.
Here, we investigated the mitochondrial and cell consequences of frataxin depletion in
a cellular model based on frataxin silencing in SH-SY5Y human neuroblastoma cells,
a cell line that has been used widely as in vitro models for studies on neurological
diseases.We showed that the reduction of frataxin induced mitochondrial dysfunction due
to a bioenergetic deﬁcit and abnormal Ca2+ homeostasis in the mitochondria that were
associated with oxidative and endoplasmic reticulum stresses. The depletion of frataxin
did not cause cell death but increased autophagy, which may have a cytoprotective effect
against cellular insults such as oxidative stress. Frataxin silencing provoked slow cell growth
associated with cellular senescence, as demonstrated by increased SA-βgal activity and
cell cycle arrest at the G1 phase. We postulate that cellular senescence might be related
to a hypoplastic defect in the DRG during neurodevelopment, as suggested by necropsy
studies.
Keywords: Friedreich ataxia, frataxin, mitochondrial dysfunction, cellular senescence, autophagy, calcium
metabolism, ER-stress
INTRODUCTION
Friedreich ataxia (FRDA) is the most common autosomal reces-
sive ataxia, with a prevalence of two to four individuals per
100,000 in Caucasian populations (Lopez-Arlandis et al., 1995;
Vankan, 2013). Both the peripheral and central nervous sys-
tems are involved. Neuropathology and clinical pictures are the
consequences of sensory axonal neuropathy characterized by
degeneration of the large sensory neurons at the dorsal root
ganglia (DRG), spinocerebellar tracts, and corticospinal tracts,
and degeneration of cerebellar deep nuclei, namely the dentate
nucleus. Hypertrophic cardiomyopathy and increased incidence
in diabetes and skeletal deformities are also characteristic of the
disease (Harding, 1981; Koeppen and Mazurkiewicz, 2013; Weide-
mann et al., 2013). Mutations in the FXN gene cause FRDA. FXN
maps to chromosome 9q13 and encodes frataxin, a small protein
of 210 amino acids (Campuzano et al., 1996) associated with the
mitochondrial innermembrane (Babcock et al., 1997; Campuzano
et al., 1997; Priller et al., 1997; Koutnikova et al., 1998). Pathophys-
iology of the disease is due to the reduced amount of frataxin in
targeted neural and non-neural cells and tissues (Deutsch et al.,
2010).
A number of physiological functions for frataxin in mitochon-
dria have beenproposed; themost accepted role is in the biogenesis
of iron-sulfur clusters (ISC; Gerber et al., 2003; Ramazzotti et al.,
2004), but other functions such as the metabolism of mitochon-
drial iron and the response to oxidative stress (Babcock et al.,
1997; Foury and Cazzalini, 1997; Wilson and Roof, 1997), an
iron-storage protein maintaining iron in a non-toxic and bioavail-
able form (Adamec et al., 2000; Park et al., 2003), maturation of
heme-containing proteins (Lesuisse et al., 2003; Yoon and Cowan,
2004), and mitochondrial energy conversion and oxidative phos-
phorylation (Ristow et al., 2000; Gonzalez-Cabo et al., 2005) have
been proposed as well. The lack of frataxin causes mitochondrial
dysfunction (Vazquez-Manrique et al., 2006; Llorens et al., 2007;
Gonzalez-Cabo and Palau, 2013), which has a direct effect on
the pathophysiology of the disease. Proper mitochondrial func-
tion is essential for the neuronal survival by different physiological
functions such as energy production, maintenance of membrane
potential, regulation of cellular Ca2+ homeostasis, protein fold-
ing by chaperones, dendritic and axonal transport, and release
and reutilization of synaptic neurotransmitters. Due to the variety
of functions that the mitochondria perform, it is not surpris-
ing that mitochondrial dysfunction has severe consequences at
the cellular level, which are intimately related to aging and neu-
rodegenerative diseases (Kwong et al., 2006; Tatsuta and Langer,
2008).
Here, we present the cellular and mitochondrial consequences
of frataxin deﬁciency in a cellular model based on gene silencing
Frontiers in Cellular Neuroscience www.frontiersin.org May 2014 | Volume 8 | Article 124 | 1
Bolinches-Amorós et al. Senescence and calcium in frataxin lack
in the human neuroblastoma cell line SH-SY5Y. Neuroblastoma is
a developmental tumor originated from the neural crest, like DRG
neurons. This shared origin makes neuroblastoma cell lines a good
cellular model to study disorders related to DRG and other neu-
ral crest-derived cells. We have observed cellular senescence and
mitochondrial dysfunction associated with low energy produc-
tion and abnormal Ca2+ homeostasis, oxidative and endoplasmic
reticulum (ER) stresses, and an increase of autophagy. The senes-
cence phenotype could be involved in the neurodegeneration and
abnormal development in the FRDA pathogenesis. The present
study, therefore, implicates calcium homeostasis, ER stress, and
cellular senescence as potential contributing factors in FRDA.
We propose these phenomena as new drug and neuroprotection
targets.
MATERIALS AND METHODS
CELL CULTURE AND PRODUCTION OF STABLE SH-SY5Y CELL LINES
The human SH-SY5Y neuroblastoma cell line was grown in
DMEM-F12 (Gibco, Invitrogen) supplemented with 10% fetal
bovine serum containing 2 mM L-glutamine and antibiotics, and
maintained at 37◦C in an atmosphere of 5% CO2 in air.
For the generation of stable cell lines with gene silencing
of FXN, SH-SY5Y cells were transfected with pLKO.1 vector
(MISSION®shRNA plasmid DNA, Sigma-Aldrich) containing a
hairpin sequence of FXN (TRCN0000006138). Control cells
were transfected with non-target control vector. Transfections
were performed using SuperFect Transfection (Qiagen) accord-
ing to the manufacturer’s instructions. The stably transfected
cells were selected and maintained in medium with 2 μg/ml
puromycin.
WESTERN BLOTTING
Cells were harvested and centrifuged (100 × g, 5 min), and the
cell pellets were re-suspended in lysis buffer (50 mM TrisHCl,
pH 7.5; 10 mM NaCl; 50 mM EDTA, pH 8; 15% glycerol) con-
taining protease inhibitors (Roche). After 30 min of incubation
on ice, cell lysates were subjected to three cycles of freeze-
thawing in liquid nitrogen. Next, the lysates were centrifuged
(15,000 x g, 4◦C, 10 min) and the supernatant was collected
to use for detection of frataxin expression. Protein extracts of
the supernatant were resolved by SDS-PAGE and transferred to
PVDF membrane. Membranes were stained with speciﬁc anti-
bodies: frataxin (Immunological Sciences), LC3 (Sigma), COX1
(Mitosciences), and COX2 (Molecular Probes), catalase (Sigma),
SOD 2 (Abnova), SOD 1 (Abnova), cytochrome c (BD Bio-
sciences), caspase-3 (Cell Signaling), BIP (cell Signaling), actin
(Sigma), and OPA1 (BD Biosciences) antibodies. Equal load-
ing was assessed using an antibody against actin (Sigma). After
incubation with the appropriate secondary antibodies, protein
bands were detected using a Fujiﬁlm Las-3000 after incubation
with the ECL PlusWestern Blotting Detection System (GE Health-
care). Density of the bands was quantiﬁed by Multi Gauge V2.1
software.
CELLULAR GROWTH CURVE CONTROL
Cells in log phase were trypsinized and seeded in six-well plates
at a density of 25,000 cells/well. The cells were trypsinized and
counted every 24 h for 13 successive days in order to complete the
growth curve in vitro.
EVALUATION OF CELL CYCLE
Samples containing 1 × 106 cells were harvested by centrifugation
at 250 × g for 10 min at 4◦C and ﬁxed with 70% cold ethanol for
at least 2 h at −20◦C. Cells were harvested by centrifugation at
2700 × g for 10 min at 4◦C and resuspended in 1 ml of PBS with
0.05 mg/ml propidium iodide (PI) and 0.25 mg/ml RNase. The
cells were incubated for 30 min at 37◦C. Cell cycle proﬁles (30,000
cells) were analyzed by a FACS Canto ﬂow cytometer (BD) with
an FL2 detector. FACS Diva software (BD) was used for analysis of
cell cycle phase.
SENESCENCE-ASSOCIATED BETA-GALACTOSIDASE (SA-βGAL) ASSAY
Cells were seeded in a six-well plate at 5000 cells/cm2. At 24 h,
the cells were incubated for 2 h with 100 nM baﬁlomycin A1 to
inhibit lysosomal beta-galactosidase. After the wells were washed
with 1× PBS, the cells were ﬁxed with 0.2% glutaraldehyde for
10 min at room temperature, washed three times with 1x PBS, and
incubated for 6 h at 37◦C in the dark with staining solution (5 mM
C6N6FeK4, 5 mM C6N6FeK3, 2 mM MgCl2, 1 mg/mL X-gal, pH
6.0). Blue cells were counted under a microscope.
MITOCHONDRIAL RESPIRATORY CHAIN ACTIVITIES
Mitochondria were prepared from SH-SY5Y cells using the Mito-
chondria Isolation Kit (Sigma) following the manufacturer’s
instructions. The ﬁnal pellet represented a crude mitochondrial
fraction. Freshly obtained mitochondria were assayed for complex
I, complex II, complex III, complex IV, complex I+II, and complex
II+III activities. All assays were measured as previously described
(Gonzalez-Cabo et al., 2010).
ATP ASSAYS
Cells were trypsinized and resuspended in 0.5 ml PBS (1 × 106
cells/ml). ATP levels were determined using the Adenosine 5′-
triphosphate (ATP) Bioluminescent Assay Kit (Sigma) following
the manufacturer’s instructions. Each sample was measured in
triplicate usingWallacVictor2TM 1420 Multilabel Counter (Perkin
Elmer).
OXYGEN CONSUMPTION ASSAY
Oxygen consumptionwas assessed using a Clark-type oxygen elec-
trode (Rank Brothers) at 37◦C with a magnetic stirrer. Cells were
suspended in 1 ml of Hank’s Balanced Salt Solution (Invitrogen).
Oxygen consumption is given in nmol O2 min−1 106 cells−1.
MITOCHONDRIAL TRANSMEMBRANE GRADIENT (ψM)
Suspended cells for all the clones (8× 105 cells/ml) were incubated
at 37◦C for 30 min with JC-1 dye (5 μg/ml; Molecular Probes,
Invitrogen). Appropriate uncoupling controls were set up by treat-
ing the cells with 500 μM of the uncoupler carbonyl cyanide
m-chlorophenylhydrazine (CCCP) at 37◦C for 5 min. ψM was
determined by ﬂow cytometry using the BD FACS Canto. The
emission of JC-1 monomers and aggregates was detected through
530 ± 15 and 585 ± 20 nm ﬁlters, respectively. The data were ana-
lyzed using BD FACS Diva software. This experiment was repeated
at least seven times.
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OXIDATIVE STRESS ASSAYS
To analyze protein carbonylation, we used the OxyblotTM
Protein Oxidation Detection Kit (Millipore). Brieﬂy, a cell
lysate containing 15 μg of protein, prepared as described
above, was incubated in 12% SDS supplemented with 2,4-
dinitrophenylhydrazine (DNPH) for 10 min at room temperature.
Samples were resolved by western blotting using an anti-DNP
antibody.
The detection of superoxide in live cells was performed
using MitoSOXTM Red superoxide indicator (Invitrogen). Cells
were seeded directly on glass coverslips in six-well plates at a
density of 20,000 cells/well. The positive control, pLKO.1-NT
cells, were treated with 50 μM H2O2 overnight. The rest
of the cell lines did not receive this treatment. The next
day, the cells were incubated with PBS containing 3.75 μM
MitoSOXTM for 10 min at 37◦C in the dark. Nuclei were
stained with DAPI (Sigma). The coverslips were then ﬁxed
on microscope slides and digitized with a Hamamatsu camera
(Tokyo, Japan) connected to a Leica DMR microscope (Nuss-
loch, Germany).To quantify superoxide production, we collected
ﬂuorescence images of more than 200 cells for each clone. We
then measured the pixels produced by ﬂuorescence in the cells
and determined the ﬂuorescence level relative to cell area, using
ImageJ.
MEASUREMENT OF APOPTOSIS
Wild-type SH-SY5Y cells were irradiated at room temperature by a
crosslinker with doses of 8 J/cm2 during 30 s. ForWestern blotting,
cells were recoveredwithin16 h after exposure to the radiation. The
rest of the cell lines did not receive this treatment.
Cytochrome c release from the mitochondria and active
caspase-3 were measured in SH-SY5Y cell lines for 72 h and 6 days.
Cell fractions were obtained (cytosolic and mitochondrial) and
then protein extracts of the cell fractions were tested by Western
blotting using cytochrome c (BD Biosciences) and caspase-3 (Cell
Signaling) antibodies. Equal loading was assessed using antibodies
against actin (Sigma) and OPA1 (BD Biosciences).
AUTOPHAGY PROCESS MEASUREMENTS
SH-SY5Y cells were transfected with pEGFP-LC3 using the lipo-
fectamine reagent (Invitrogen) according to the manufacturer’s
instructions. After 24 h of transfection, the cells were analyzed by
ﬂuorescence microscopy.
Autophagy was induced in SH-SY5Y cells cultured in DMEM-
F12 without fetal bovine serum overnight. To inhibit autophagy,
the cells were treated with different pharmacological or molecular
inhibitors: 0.1 μM of baﬁlomycin A1 (Sigma) for 2 h (inhibitor of
the late phase of autophagy), 100 nM insulin (Sigma) for 90 min,
or 1 μM phorbol 12-myristate 13-acetate (PMA, Sigma) for 2 h.
After the treatments, the cells were harvested and lysed to test
variations in LC3-II levels by Western blotting.
ENDOPLASMIC RETICULUM STRESS
Susceptibility to ER stress was assessed as described byVernia et al.
(2009). Brieﬂy, SH-SY5Y cells were treatedwith 1μMthapsigargin
(AlomoneLabs) andweremaintained in culture during 18hbefore
analysis by Western blotting.
To analyze apoptosis, samples containing 1 × 106 treated cells
were harvested by centrifugation at 250 × g for 10 min at 4◦C
and ﬁxed with 70% cold ethanol for at least 2 h at −20◦C. Cells
were harvested by centrifugation at 2700 × g for 10 min at 4◦C
and resuspended in 1 ml PBS with 0.05 mg/ml PI and 0.25 mg/ml
RNase. The cells were incubated for 30 min at 37◦C. Cell cycle pro-
ﬁles (30,000 cells) were analyzed by a FACS Canto ﬂow cytometer
(BD) with an FL2 detector. FACS Diva software (BD) was used for
analysis of cell cycle phase.
MEASUREMENTS OF [Ca2+]CYT AND MITOCHONDRIAL Ca2+ UPTAKE
Cytosolic calcium imaging with Fura-2 was performed as
described by Pla-Martin et al. (2013). Changes in ﬂuorescence
ratio were recorded after the addition of 25 μM veratridine
(Sigma) in 2 mM CaCl2–HCSS medium or 100 μM 2,5-di-
(ter-butyl)-1,4-benzohydroquinone (tBuBHQ, Alomone Labs) in
Ca+2-free HCSS medium. To activate store-operated calcium
entry (SOCE) induced by ER calcium release with tBuBHQ, 2 mM
CaCl2 was added. Images were analyzed using Leica MM Fluor
software.
To study mitochondrial calcium uptake and swelling, we
adapted the protocol described by Traba et al. (2012). The exper-
iments were carried out in a Wallac Victor2TM 1420 Multilabel
Counter (PerkinElmer) at 30◦C in the presence of 5 mM succi-
nate, 1 μM rotenone, and 100 μM ADP. Mitochondrial calcium
uptakewas assessed bymonitoring the decrease in CalciumGreen-
5Nﬂuorescence at 535 nmevery 7min after adding pulses of 4mM
CaCl2.
MEASURING MITOCHONDRIAL LENGTH AND NUMBER
Cells were probed with anti-cytochrome c antibody to determine
mitochondrial length and number. To obtain quantitative data, a
number of cells (n = 14–31) were typically imaged. Morpholog-
ical measurements were made using ImageJ by automated object
identiﬁcation with user-deﬁned thresholds for pixel intensity and
size. Objects were skeletonized and measurements of length were
obtained.
MICROSCOPY STUDIES
Cells were seeded directly on glass coverslips. Twenty-four hours
later, they were ﬁxed with 2 and 4% paraformaldehyde solution
successively and then permeabilized with a solution of 0.5% PBS-
Triton X-100. Cells were probed with anti-cytochrome c antibody
(Zymed) in blocking solution (PBS/3% FBS) and then with ﬂuo-
rescent Alexa Fluor 488 (Molecular probes). Similarly, cells were
stained with DAPI (Sigma) to visualize nuclei. Appropriate nega-
tive controls were set up by incubating ﬁxed cells with secondary
antibodies only. Coverslips were then ﬁxed on microscope slides
and digitizedwith aHamamatsu camera (Tokyo, Japan) connected
to a Leica DMR microscope (Nussloch, Germany). All images
were captured under constant exposure time, gain, and offset.
We deﬁned four different mitochondrial architectures in live cells:
tubular (long and higher interconnectivity), mixed (mixture of
tubular and vesicular), vesicular (short tubular segments), and
fragmented (small and round). Mitochondrial morphology eval-
uation was performed by a researcher blinded to genotype. At least
100 cells were counted and the average was calculated.
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ELECTRON MICROSCOPY
Cells were seeded at 2000 cells/cm2 in Lab-Tek chamber slides of
two wells (Nalge Nunc International, Naperville, IL, USA) and
were ﬁxed in 2.5 % glutaraldehyde for 1 h at 37◦C. Subsequently,
a standard protocol (Marcilla-Etxenike et al., 2012) was applied in
these cells to obtain ultrathin sections. Photomicrographs were
obtained under a transmission electron microscope FEI Tecnai
G2 Spirit (FEI Europe) using a digital camera Morada (Olympus
Soft Image Solutions GmbH). At least 20 cells of each clone were
analyzed.
RESULTS
SILENCING OF FXN EXPRESSION INDUCES CELLULAR SENESCENCE
BUT NOT APOPTOSIS
To investigate the consequences of frataxin depletion in cells and
mitochondria, we generated FXN-silenced clones of the human
neuroblastoma SH-SY5Y cell line using ﬁve different shRNA tar-
geted to ﬁve different sites on the FXN gene. Clones FXN-138.1
and FXN-138.2 (82 and 78% frataxin reduction, respectively) were
used for further experiments (Figure 1).We observed that the pro-
liferation of both silenced clones was limited compared with both
the WT neuroblastoma cells and the non-targeted shRNA clone
(pLKO.1-NT) used as a negative control, in a time-dependent
manner (Figure 2A). Limited proliferation was conﬁrmed by
ﬂow cytometry that showed signiﬁcant reduced progression to
the G2/M and S phase and growth arrest at G1 in knockdown
cells (Table 1). We did not detect a loss of cell viability in silenced
clones, suggesting that the depletion of frataxin did not induce cell
death.
Furthermore, neither FXN-138.1 nor FXN-138.2 expressed
cleaved caspase-3 (Figure 2B), nor did they show increased lev-
els of cytosolic cytochrome c (Figures 2B,C) in basal conditions
after 72 h and 6 days of culture, which suggested that the lack of
frataxin in the SH-SY5Y cells did not induce apoptosis. Then, we
investigated cellular senescence in the knockdown cells by measur-
ing the senescence-associated β-galactosidase (SA-β-gal) activity
FIGURE 1 | Depletion of frataxin by siRNA. SH-SY5Y cells were
transfected with the vector pLKO-FXN. Two SH-SY5Y stable clones
exhibiting the most efﬁcient silencing were selected, FXN-138.1 and
FXN-138.2. (A) Cell lysates were analyzed by SDS-PAGE and
immunoblotting for frataxin (bottom panel; upper and lower bands
correspond to intermediate and mature forms of frataxin, respectively).
Beta-tubulin was used as a loading control (top panel). (B) Bands
corresponding to mature frataxin were quantiﬁed and ﬁnal values are
expressed as a percentage of the pLKO.1-NT value. Student’s t -test,
FXN-138.1 p = 0.025, FXN-138.2 p = 0.019 versus pLKO.1-NT. *p ≤ 0.05.
(Figure 2D). We observed a signiﬁcant increase of SA-β-gal pos-
itive cells (Student’s t-test, FXN-138.1 p = 0.001, FXN-138.2
p = 0.02) which conﬁrmed the senescent phenotype of cells with
reduced amounts of frataxin (Figure 2E).
DEPLETION OF FRATAXIN AFFECTS MITOCHONDRIAL BIOENERGETICS
AND INDUCES OXIDATIVE STRESS
We investigated the bioenergetic metabolism of FXN-silenced
clones in cell culture for 1month bymeasuring oxidative phospho-
rylation (OXPHOS), electron transport chain (ETC) complexes,
and mitochondrial membrane potential. We observed a signif-
icant reduction of ATP production (Figure 3A) and a decrease
of oxygen consumption (Figure 3B) in FXN-depleted clones,
which suggested a defect in energy metabolism. Then, we mea-
sured the enzymatic activities of ETC complexes. The depletion
of frataxin was associated with the loss of complex IV activ-
ity (Figure 4). The loss of enzymatic activity was correlated
with a reduction in the amount of two complex IV subunits,
cytochrome c oxidase subunits 1 and 2 (COX1 and COX2;
Figure 3C). Mitochondrial inner membrane potential (m)
was also altered, as the JC-1 label showed a signiﬁcant increase of
the JC-1 green/red ratio, indicating depolarization of the mito-
chondrial membrane in both FXN-silenced clones compared with
pLKO.1-NT control cells (Figure 3D). Taken as a whole, these
ﬁndings indicated that silencing of the FXN gene in SH-SY5Y
cells affected energy metabolism and suggested that the abnormal
mitochondrial function was the consequence of the partial loss of
frataxin.
Mitochondria are the principal source of reactive oxygen
species (ROS) within the cell, including the superoxide radi-
cal anion (O•−2 ) and hydrogen peroxide (H2O2). Mitochondrial
OXPHOS dysfunction may increase ROS production, with a
damaging effect on these organelles. Frataxin knockdown cells
showed a reduction of complex IV activity and reduced levels
of COX1 and COX2 subunits. To determine whether frataxin
down regulation induced oxidative stress, we investigated the
production of O•−2 and the effects of increased free radical lev-
els on proteins. The quantitation of O•−2 by the MitoSOXTM
probe showed a signiﬁcant increase in frataxin-depleted clones
against pLKO.1-NT control cells (Figures 5A,B; Student’s t-test,
FXN-138.1 p = 1.8 × 10−7, FXN-138.2 p = 6 × 10−14). As
positive control we used pLKO.1-NT cells treated with H2O2.
Proteins showed the tendency for carbonylation in silenced
clones (Figure 5C), suggesting again that an effect of ROS was
associated with frataxin depletion. Such an increase in oxida-
tive stress, however, did not induce any speciﬁc response of
antioxidant defenses, as protein expression of superoxide dismu-
tases, MnSOD and CuZnSOD, and catalase was not signiﬁcantly
modiﬁed (Figure 6).
DEFICIT OF FRATAXIN INDUCES MITOCHONDRIAL FUSION
Maintenance of the mitochondrial network is fundamental for
the normal function of mitochondria and their adaptation to
different metabolic and energetic needs of different tissues in
homeostasis and disease. Mitochondrial division is usually associ-
ated with apoptosis (Frank et al., 2001); in contrast,mitochondrial
fusion protects cells from apoptotic cell death (Olichon et al.,
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FIGURE 2 | Increased cellular senescence response in FXN -deficient
clones. (A) Growth curves of SH-SY5Y (wild-type), pLKO.1-NT, FXN-138.1,
and FXN-138.2 cells. The cells were trypsinized and counted every 24 h for
13 successive days. Data are expressed as the mean of three experiments.
(B) Western blot analysis of extracts from cells after 6 days of culture from
untreated wild-type (WT) SH-SY5Y, pLKO.1-NT, FXN-138.1, and FXN-138.2
cells and WT SH-SY5Y cells exposed to radiation (apoptotic control), using
cleaved caspase-3 antibody and cytochrome c antibody. Only the apoptotic
control showed caspase-3 activation. All clones retained cytochrome c in
the mitochondria, which is consistent with a non-apoptotic state, while the
apoptotic control showed cytochrome c release into the cytosol. (C) A
quantitative Western blot assay was developed to measure total
cytochrome c in the mitochondria and cytosol. Data from cytosolic
cytochrome c are expressed as percentage relative to apoptotic control,
whereas data from mitochondrial cytochrome c are expressed as
percentage relative to pLKO.1-NT control. (D) The clones indicated in the
pictures were subjected to in situ SA-β-gal staining (blue) and examined by
bright ﬁeld microscopy. (E) The ﬁgure represents the expression level of
the lysosomal enzyme β-galactosidase in all lines. The columns and bar
show the mean and standard deviation of no fewer than 1300 cells from at
least three experiments. Student’s t -test, FXN-138.1 p = 0.001, FXN-138.2
p = 0.02 versus pLKO.1-NT. *p ≤ 0.05; ***p ≤ 0.001.
2003). As the silenced clones expressed a senescent pheno-
type with no evidence of apoptosis, we wanted to know the
dynamics of the mitochondrial network. As expected, we did
not observe a fragmented pattern. On the contrary, frataxin-
depleted cells showed a fusion network with tubular mor-
phology (Figures 7A,B), a reduced number of mitochondria
(Figure 7C; Student’s t-test; FXN-138.1 p = 0.00006, FXN-138.2
p = 0.00004), and an increase of the number of large organelles
as the major pattern (Figure 7D). Electron microscopy images
are consistent with the tubular pattern observed. A qualita-
tive assessment showed small round mitochondria in control
clone (Figure 7E), and tubular pattern and altered morphology
with swollen mitochondria are observed in clone FXN-138.1
(Figures 7F,G).
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Table 1 | Distribution of cell cycle phases (%) of wild-type (WT)
SH-SY5Y, pLKO.1-NT, FXN-138.1, and FXN-138.2 cells.
WT SH-SY5Y pLKO.1-NT FXN-138.1 FXN-138.2
SubG0 1.63 ± 0.38 2.90 ± 0.44 2.20 ± 0.50 6.07 ± 4.05
G1 64.60 ± 7.20 70.93 ± 3.65 82.73 ± 1.69∗ 76.17 ± 7.33
S 22.70 ± 6.33 16.13 ± 3.88 8.5 ± 1.21# 10.77 ± 5.35
G2/M 10.27 ± 0.95 9.17 ± 0.84 5.87 ± 0.45& 6.43 ± 1.43
Student’s t-test, ∗p = 0.007; #p = 0.031; &p = 0.004; p = 0.046.
FRATAXIN DEFICIENCY IS ASSOCIATED WITH INCREASED BASAL
AUTOPHAGY
Autophagy has a cardinal role in cellular quality control and is
involved in oxidative stress-induced adaptation, as a defensive
mechanism against oxidative injuries (Chu, 2006). In our frataxin
deﬁciency cell model, we observed several phenomena that might
trigger autophagy, such as the decrease of OXPHOS activities
and decline of the m. Moreover, the accumulation of numer-
ous lysosomal vesicles observed by electron microscopy could be
related to the increase of basal autophagy (Figure 7F). Based
on these ﬁndings, we investigated the balance of the autophagy
pathway in frataxin-depleted clones. We measured the expression
of LC3-II as a major regulator of autophagosome formation in
both baseline conditions and after induction or inhibition of the
autophagy signaling pathway. In baseline conditions, frataxin-
deﬁcient cells showed an increase of both LC3-II expression, as
measured by Western blot analysis (Figure 8A), and the num-
ber of cells containing GFP-LC3 puncta (Figures 8B,C), which
indicated autophagy induction.
Then, we investigated the cellular status of the autophagic
pathway. We induced autophagosome formation by adding
baﬁlomycin A1, which blocks the fusion of autophagosomes with
lysosomes and prevents the degradation of LC3-II, or by the
removal of serum in cultures. We also inhibited autophagy by
either insulin or PMA, which stimulate the mTORC1 pathway
that further negatively regulates autophagy. We observed that WT
cells, pLKO.1-NT control cells and knockdown clones responded
properly to the induction of autophagosome formation and to
autophagy inhibition (Figure 8D). These ﬁndings suggested that
the reduction of cellular frataxin levels did not affect the autophagy
machinery per se. Interestingly, when data from knock-down
clones were compared to those from the pLKO.1-NT clone we
observed that depletion of frataxin was associated with signiﬁ-
cant baseline increase of LC3-II, a trend that was also observed
for the other experimental conditions (Figure 8E). This ﬁnding
suggest that these cells could be more susceptible to an increase in
autophagy activity against cellular insults such as oxidative stress
or bioenergetic deﬁcit, and that autophagymight be cytoprotective
in cells when frataxin is depleted.
FIGURE 3 | Alterations in mitochondrial bioenergetics in
frataxin-deficient cells. (A) ATP synthesis was measured in all the clones
and was reduced in frataxin-deﬁcient cells. Error bars indicate the standard
deviation (SD) of at least three independent assays. Student’s t -test,
FXN-138.1 p = 0.034, FXN-138.2 p = 0.003 versus pLKO.1-NT. (B) Oxygen
consumption was assessed using a Clark-type oxygen electrode. Oxygen
consumption was lower in clones deﬁcient in frataxin. Student’s t -test,
FXN-138.1 p = 0.035, FXN-138.2 p = 0.00004 versus pLKO.1-NT. (C)Western
blot analysis of Complex IV of mitochondrial extracts from all the cells
conﬁrmed less COX1 and COX2 protein in frataxin-deﬁcient clones, which
correlated with results of Complex IV activity. Results are representative of at
least three experiments with similar results. (D) Quantiﬁcation of
mitochondrial membrane potential in SH-SY5Y clones analyzed by FACS.
Shown in this ﬁgure is the ratio of green/red ﬂuorescence for the different
clones. We observed depolarization of membrane potential in FXN -deﬁcient
clones. Student’s t -test, FXN-138.1 p = 0.001, FXN-138.2 p = 0.050 versus
pLKO.1-NT. The columns and bar show the mean and SD of at least three
experiments. *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001.
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FIGURE 4 | Enzymatic activity analysis of the ETC in SH-SY5Y
clones. Wild-type SH-SY5Y, pLKO.1-NT, FXN-138.1, and FXN-138.2
cells were grown for 1 month. Mitochondria were isolated and used
to determine the enzymatic activity of Complex I, II, III, IV, I+II,
and I+III of the respiratory chain. Error bars indicate the standard
deviation of at least three independent measurements (Student’s
t -test, FXN-138.1 p = 0.0063, FXN-138.2 p = 0.002 versus
pLKO.1-NT. **p ≤ 0.01).
FRATAXIN DEPLETION CAUSES ENDOPLASMIC RETICULUM STRESS
The stress response is a major signaling pathway that regulates
autophagy. The depletion of frataxin in SH-SY5Y cells was asso-
ciated with increased susceptibility to autophagy, but also with
the presence of oxidative stress. In order to deepen into the char-
acterization of the cellular stress status, we investigated the ER
stress pathway, as it is stimulated by ROS but also upregulates
autophagy. To determine the effect of frataxin silencing on ER
stress, we analyzed levels of the unfolded protein response (UPR)-
related chaperone BiP/Grp78. This protein was not increased in
baseline conditions; however, a signiﬁcant increase of BiP/Grp78
expression was obtained in frataxin-depleted cells after treatment
with thapsigargin (Figures 9A,B).
Under conditions of prolonged stress signals, the UPR can
induce apoptosis (Rao et al., 2004). In our models, we observed
that the level of cell death induced by ER stress was related to
frataxin levels. Thapsigargin induced cell death in both control and
knockdown clones, but it was signiﬁcantly higher in the silenced
clones suggesting that reduction of frataxin levels increases ER
stress susceptibility (Figure 9C). To conﬁrm whether the increase
in cell death is related to UPR-apoptotic activation, we analyzed
caspase-3 activation byWestern blot (Figure 9C).We found strong
caspase-3 activation in thapsigargin treated cells. Thus, a pro-
longed exposure to ER stress of frataxin-depleted cell induces
apoptotic cell death.
FRATAXIN DEFICIENCY AFFECTS MITOCHONDRIAL Ca2+ UPTAKE
CAPACITY
Inter-organelle communication between themitochondria andER
affectsmitochondrial distribution anddynamics and is relevant for
the proper physiology of severalmetabolic and signaling pathways.
Interaction occurs at the mitochondria-associated membranes
(MAMs) that create speciﬁc environments for the localization and
function of molecules that participate in cell metabolism such
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FIGURE 5 | Detection of protein oxidation and superoxide abundance.
(A) Detection of superoxide in live cells of SH-SY5Y clones using
MitoSoxTM Red superoxide indicator. Representative images of MitoSOX
stained cells fromSH-SY5Y, pLKO.1-NT, FXN-138.1, and FXN-138.2.
pLKO.1-NT was treated with or without H2O2. (B) Quantitative analysis of
MitoSOX red ﬂuorescence intensity. Fluorescence level is presented
relative to cell area in every clone. Student’s t -test, FXN-138.1
p = 1.8 × 10−7, FXN-138.2 p = 6 × 10−14 versus pLKO.1-NT. (C)
OxyblotTM assay on wild-type SH-SY5Y, pLKO.1-NT, FXN-138.1, and
FXN-138.2 cells. Carbonylated proteins were quantiﬁed for each lane using
Fujiﬁlm’s Multi-Gauge Software. To allow for loading variation, values were
normalized to the actin control. Final values are expressed as a percentage
of pLKO.1-NT value and shown below each lane. It can be seen that
FXN-138.1 and FXN-138.2 cells showed a marked increase in carbonylated
proteins, demonstrating direct evidence of cellular oxidative stress.
***p ≤ 0.001.
as calcium homeostasis (Marchi et al., 2013). ER is the major
cellular structure for Ca2+ storage and proper ER-mitochondria
communication supports Ca2+ release and buffering (Cali et al.,
2012). Since frataxin deﬁciency induced signiﬁcant changes of
mitochondrial physiology and ER stress, calcium metabolism
and mitochondrial buffering might be disturbed in the knock-
down clones. To test this possibility, we used agents that increase
cytosolic Ca2+and mobilize ER-Ca2+. Veratridine increases intra-
cellular Ca2+ by opening voltage-dependent Na+ channels and
then voltage-activated calcium channels. tBuBHQ is an inhibitor
of SERCA, the ER Ca2+-ATPase that allows net Ca2+ leak from
the ER. The emptying of ER-Ca2+ stores activates Ca2+ entry
through low-conductance plasmalemmal channels that are reg-
ulated by SOCE (Putney and Thomas, 2006). The Ca2+ buffer
capacity, measured as the differences between the maximum
calcium peak and the stabilization of the response showed a
defect in frataxin depleted clones (Figure 10A). Moreover, the
percentage of Ca2+ levels recovery, measured as the different
between maximum and minimum ﬂuorescence during veratri-
dine induction, suggested again a problem in buffering capacity.
Whereas both WT and pLKO.1-NT cells restored [Ca2+]cyt levels
after veratridine treatment (70 and 67% respectively), frataxin-
deﬁcient cells failed to recover normal Ca2+ cytosolic concentra-
tions (37% for FXN-138.1 and 11% for FXN-138.2). Thus, we
investigated Ca2+ release from the ER by measuring [Ca2+]cyt
in Ca2+-free medium and inhibition of the SERCA pump by
tBuBHQ. Again, FXN-silenced clones did not show reduced cal-
cium levels after Ca2+ release from the ER (Figure 10B). The
percentages of Ca2+ levels recovery were 49% for SH-SY5Y
and 53% for pLKO.1-NT versus 22% for FXN-138.1 and absent
in FXN-138.2, conﬁrmed abnormal buffering of intracellular
Ca2+ levels. Mitochondrial buffering is crucial to properly cal-
cium inﬂux by store-operated calcium channels. The induction
of SOCE by ER-calcium released was reduced in the frataxin
silenced cells compared to control clones (Figure 10B, upper
right panel). To test whether the abnormal Ca2+ buffering in
FXN-silenced clones was due to mitochondrial buffering capacity
dysfunction, we performed Ca2+ uptake capacity experiments in
digitonin-permeabilized cells in the presence of Calcium Green
5N. In contrast to WT and control cells, FXN-silenced cells were
unable to take up Ca2+ in the mitochondria, which indicated
a strong defect in Ca2+ buffering by mitochondria deﬁcient for
frataxin (Figures 10C–E). Then, an excess of local [Ca2+]cyt in
frataxin deﬁcient cells due to the inability of mitochondria to
uptake calcium, might induce a negative feedback of the SOCE
mechanism.
DISCUSSION
In order to investigate the effects of a lack of frataxin on cellular
homeostasis, we developed a cell model of frataxin deﬁciency by
FXN gene silencing in the human neuroblastoma cell line SH-
SY5Y. The main advantage of this model is that neuroblastoma
cells are derived from the neural crest, which is the developing
structure of the nervous system that gives rise to neurons from the
DRG, the major target structure involved in FRDA neuropathol-
ogy. The two knockdown cell clones, FXN-138.1 and FXN-138.2,
showed maintained reduction of frataxin over time, simulating a
chronic deﬁciency.
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FIGURE 6 | Analysis of antioxidant enzymes.Western blots analyses of
antioxidant enzymes were carried out. Once normalized the intensities, the
protein levels of antioxidant enzymes are expressed as percentages versus
control pLKO.1-NT: (A) catalase, (B) MnSOD, and (C) CuZnSOD. The columns
and bar represent the mean and standard deviation of at least three
experiments.
Frataxin silencing induced slow cell growth, similar to those
reported in several cellular models of frataxin deﬁciency (Zanella
et al., 2008; Calmels et al., 2009; Lu et al., 2009). In our cell model,
slow growth was not associated with apoptotic cell death but
with cellular senescence, as demonstrated by increased SA-βgal
activity and cell cycle arrest at the G1 phase. We have also
found that frataxin deﬁciency is associated with mitochondrial
elongation and, interestingly, morphodynamic changes of mito-
chondria closely link to the cell cycle (Lee et al., 2013) and
mitochondrial elongation concretely triggers cellular senescence
(Lee et al., 2007).
The relationship between frataxin deﬁciency and apoptosis
remains unclear. Cortopassi and colleagues (Lu et al., 2009) in
their study of the effect of frataxin silencing in several neural cell
lines observed that only one Schwann cell-derived line exhibited
viability decrease. By contrast, cell death associated with frataxin
deﬁciency has been reported in a neuroblastoma cell line (Palomo
et al., 2011) and rat DRG neurons (Mincheva-Tasheva et al., 2013).
In the SH-SY5Y cells, large-scale apoptosis was observed after
neuron-like differentiation, but not if differentiation was not
induced (Palomo et al., 2011). We think that the different apop-
totic response may be due to differential effects of permanent
frataxin silencing versus transitory depletion. Maintained deple-
tion may favor cell adaptation, which could promote molecular
mechanisms to prevent cell death, such as autophagy.
To determine the biological status of these senescent cells and
the pathogenic mechanisms associated with frataxin deﬁciency,
we investigated several mitochondrial and cellular functions and
pathways. We observed that the partial lack of frataxin pro-
voked changes in mitochondrial function and network dynamics,
induced the increase of the autophagy threshold, induced cellular
stress, and affected normal calcium metabolism management by
the mitochondria.
Energy depletion and inner membrane potential depolariza-
tion, with a reduction of complex IV activity, suggest malfunction
of the ETC and oxidative phosphorylation. Alterations of the res-
piratory chain activities associated with frataxin deﬁciency have
been described but the biological consequences depend on the
cell models and patient tissues investigated. Reduced activities of
ETC complexes have been observed (Rotig et al., 1997; Bradley
et al., 2000; Gonzalez-Cabo et al., 2010), but there is no evidence
of ETC involvement in patients’ nervous system (Bradley et al.,
2000), conditional knockout mice (Puccio et al., 2001), or neurons
derived from reprogrammed iPS cells (Hick et al., 2013). Mito-
chondria are the major source of ROS production, mainly the
superoxide anion O•−2 and H2O2. The increase of O
•−
2 radical and
protein carbonylation we observed in FXN-silenced clones agrees
with previous reports (Gonzalez-Cabo and Palau, 2013) and con-
ﬁrms the role of oxidative stress in the pathogenesis of frataxin
deﬁciency.
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FIGURE 7 | Quantification of mitochondrial dynamic process in
SH-SY5Y clones. (A) Representative mitochondrial network shows
increased fusion morphology in frataxin-deﬁcient cells. (B) Quantiﬁcation
of four different mitochondrial architectures within the cell: tubular,
mixed (tubular and vesicular), vesicular, and fragmented. (C) Average
number of mitochondria per cell in all the clones. Error bars indicate
the standard deviation. Student’s t -test, FXN-138.1 p = 0.00006,
FXN-138.2 p = 0.00004 versus pLKO.1-NT. (D) Mitochondrial length
distribution in all the clones. We observed fewer mitochondria but
higher mitochondrial length in frataxin-deﬁcient cells than in control.
Electron microscopy images of pLKO.1-NT control (E) and clone
FXN-138.1 (F,G) show normal and long tubular mitochondria, respectively
(∗). Clone FXN-138.1 (G) apparently shows increased mitochondrial
fusion morphology. Frataxin-deﬁcient cells appeared to have higher
lysosomal content (black arrow), with residual bodies (boxed) and
vacuoles (white arrow). ∗∗∗p ≤ 0.001.
The maintenance and proper connection of both function
and morphology are fundamental in mitochondrial homeostasis
(Nunnari and Suomalainen, 2012). In fact, an imbalance between
fusion and ﬁssion activities results in dysfunctional mitochondria.
Frataxin knockdown cells showed a tubular pattern that indicates
fusion activity of the mitochondrial network. However, in the
same way, the induction of fusion should be associated with high
OXPHOS activity and an increase in mitochondrial membrane
potential, which were not observed in frataxin-depleted cells. This
apparent contradictory response of mitochondrial physiologymay
be related to an attempt of the mitochondrial network to buffer
respiratory defects and oxidative stress (Chen et al., 2005, 2007).
Hyperfused mitochondria should protect cells from apoptotic
cell death, which agrees with our observation in the knockdown
clones. The increased expression of the autophagosome marker
LC3-II in knockdown cells suggests that the reduction of frataxin
induces autophagy in basal conditions. Autophagymay be induced
by a wide variety of cellular stresses, including nutrient depriva-
tion, high bioenergetic demands, changes in redox metabolism
with the production of ROS, infection, protein aggregate accumu-
lation, and hypoxia (Scherz-Shouval and Elazar, 2007; Kroemer
et al., 2010; Murrow and Debnath, 2013). Pharmacological analy-
sis of the autophagy pathway by inhibition with baﬁlomycin A1 or
nutrient starvation, or by induction of the mTORC1 pathway with
either insulin or PMA conﬁrmed that autophagy signaling func-
tioned properly in frataxin deﬁciency. Thus, the observed over
active autophagy in frataxin-depleted cells might be the conse-
quence of a cytoprotective response to abnormal mitochondrial
homeostasis manifested by the reduction of cell respiration and
m and the induction of oxidative stress.
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FIGURE 8 | Effects of frataxin deficiency on the autophagy process. (A)
Western blotting using anti-microtubule chain 3 (LC3) antibody. We detected
LC3-I conversion and LC3-II turnover. The ﬁgure shows an increase level of
LC3-II in FXN -deﬁcient cells. Results are representative of ﬁve experiments.
Proteins were quantiﬁed for each lane using Fujiﬁlm’s Multi-Gauge Software.
To allow for loading variation, values were normalized to the actin control. (C)
Cells were transfected with EGFP-LC3 and, after culturing for an additional
24 h in complete medium, were examined by confocal ﬂuorescence
microscopy. Frataxin depletion increased GFP-LC3 puncta in SH-SY5Y cells,
while puncta were not found in GFP control cells. (B)The percentage of cells
showing GFP-LC3 aggregates was quantiﬁed. Data are means ± standard
deviations from three independent experiments. At least 300 cells were
analyzed for each. Student’s t -test, FXN-138.1 p = 0.021, FXN-138.2
p = 0.043 versus pLKO.1-NT. (D)The autophagyc response was assessed by
culturing cells in different conditions: with 0.1 μM baﬁlomycin A1, in the
absence of serum, with 100 nM insulin, or with 1 μM PMA. LC3-II
quantiﬁcation showed no alteration of autophagyc ﬂux in any clone when
compared versus itself in the basal condition. (E) FXN -deﬁcient cells
presented elevated levels of the autophagy marker in every condition with
respect to control cells (pLKO.1-NT). Baseline condition (Basal), plus
baﬁlomycin (+BAF), without fetal bovine serum (-FBS), plus insulin (+INS),
plus phorbol 12-myristate 13-acetate (+PMA). Student’s t -test was applied for
statistics. Both FXN-138.1 (p = 0.003) and FXN-138.2 (p = 0.002) shown
statistical differences in basal condition versus pLKO.1-NT. After FBS
starvation only the FXN-138.1 clone (p = 0.013) shown statistical differences.
*p ≤ 0.05; **p ≤ 0.01.
Thewholemetabolic scenario triggered by the partial reduction
of frataxin in SH-SY5Y cells relates mitochondrial dysfunc-
tion and fusion, cellular response to stress, and mitochondrial
Ca2+ homeostasis. The incapacity of the mitochondria to buffer
Ca2+ release might be due to inner membrane depolarization
and the changes in redox metabolism associated with abnormal
ROS production. Both oxidative stress and low cytosolic Ca2+
buffering by the mitochondria may induce other cellular stress
responses such as ER stress, but not apoptosis unlike other
authors have related (Mincheva-Tasheva et al., 2013). These patho-
logical responses may ﬁnally trigger the autophagy response in
an attempt to avoid cytotoxicity and cell death. Evidence of
autophagy involvement in frataxin deﬁciency has been observed
in some FRDA mouse models. Histological study of the DRG
showed degeneration of large sensory neurons, with the pres-
ence of vacuoles and lipofucsin accumulation, both lesions related
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FIGURE 9 | FXN depletion results in increased endoplasmic reticulum
(ER) stress. (A) Western blot analysis of ER stress marker BIP in control
and FXN-deﬁcient cells in three independent samples. (B) Normalized
intensities expressed as a percentage of the BIP intensity shown in (A).
Actin was used as a loading control. The columns and bar show the mean
and standard deviation. Student’s t -test, FXN-138.1 p = 0.008, FXN-138.2
p = 0.023 versus pLKO.1-NT. (C) Quantiﬁcation of apoptotic cells by ﬂow
cytometry. Untreated cells (white bars) and cells treated with thapsigargin
(TG, black) were ﬁxed and stained with propidium iodine. The subG1
population was quantiﬁed at least in three independent experiments. Bars
show mean ± standard deviation. Student’s t -test was applied for
statistics. Every cell types were compared between basal condition and
with TG: SH-SY5Y p = 0.16, pLKO.1-NT p = 0.042, FXN-138.1 p = 0.032,
FXN-138.2 p = 0.001. Comparison after TG treatment between pLKO.1-NT
and FXN-138.1 p = 0.050, and FXN-138.2 p = 0.00004. The activation of
caspase-3 was tested by western blot (lower panel) using speciﬁc antibody
in resting conditions (−) and TG-treated cells (+). *p ≤ 0.05; **p ≤ 0.01;
***p ≤ 0.001.
to the autophagy process (Simon et al., 2004; Al-Mahdawi et al.,
2006). We think that autophagy has a protective function for
maintaining cellular health in frataxin-deﬁcient cells, since the
cells are able to eliminate the mitochondrial damage and oxi-
dized proteins to survive, even though the autophagy response
is not enough to avoid ER stress-induced apoptosis. Silencing
of the FXN gene induced ER stress after depletion of ER Ca2+
stores by the inhibition of SERCA pumps. Moreover, ER stress
promoted more apoptosis in knockdown clones than control
cells. In addition, frataxin-depleted cells failed to buffer Ca2+
properly, as a consequence of reduced Ca2+ uptake capacity
of the mitochondria that could explain the negative feedback
of SOCE mechanism by the excess of local cytosolic calcium.
Thus, it is plausible that the apoptosis induced by ER stress
may be the consequence of anomalous Ca2+ management by
the mitochondria. Such Ca2+-induced cell toxicity could be
eliminated by normalizing intracellular calcium (Wong et al.,
1999).
Cellular senescence is a program executed by cells in response
to a variety of stresses, mainly associated with cancer and aging
(Rodier and Campisi, 2011). Based on the biological phenotype
of our cellular model of frataxin depletion, we think that the cells
had acquired a senescent phenotype to avoid death cell. Cellular
senescence has not been previously described in FRDA patients or
disease models. How could cellular senescence contribute to the
pathophysiology of disease? Cell senescence entails a loss of func-
tionality, and hence the appearance of an age-related phenotype
or early aging. Recently, cellular senescence has been assigned a
direct role in embryonic development (Munoz-Espin et al., 2013).
Thus, the loss of cellular functionality could affect the neuroge-
nesis program and alter proper development of the peripheral
nervous system. In their recent necropsy studies, Koeppen and
Mazurkiewicz (Koeppen and Mazurkiewicz, 2013) have suggested
that FRDA neuropathology may be interpreted as a combination
of developmental delay and degeneration. These authors observed
that major lesions in the central nervous system involving the
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FIGURE 10 | Calcium homeostasis in frataxin-depleted SH-SY5Y cells.
(A) Changes in fura-2 [Ca2+]cyt ﬂuorescence intensity after addition of
25 μM veratridine. The recovery slopes for each clone after calcium entry
(right, lower panel) show the difference in behavior for calcium buffering
between control and frataxin-depleted clones. Traces represent means of
no fewer than 100 cells from at least ﬁve experiments. (B) Changes in
fura-2 [Ca2+]cyt ﬂuorescence intensity after addition of 100 μM tBuBHQ in
Ca2+-free medium. The recovery slopes for each clone after emptying of
calcium from the endoplasmic reticulum (right, lower panel) show the
different behavior for calcium buffering between control and
frataxin-depleted clones. The activation of SOCE with the addition of 2 mM
Ca2+ to cells treated with 100 μM tBuBHQ in Ca2+-free medium is
altered in frataxin-depleted cells (right, upper panel) as the activation of the
process is lower than in the control cells. Traces represent means of no
fewer than 100 cells from at least three experiments. (C) Changes in
Calcium Green-5N ﬂuorescence in digitonin-permeabilized cells after the
addition of pulses of 4 nmol of Ca2+. Traces represent means of at least
four experiments for each clone. The Ca2+ uptake velocity [(D); Student’s
t -test, FXN-138.1 p = 0.0004, FXN-138.2 p = 0.0004 versus pLKO.1-NT]
and capacity [(E) ;Student’s t -test, FXN-138.1 p = 0.0002, FXN-138.2
p = 0.0002 versus pLKO.1-NT] rates were calculated from the uptake
slopes in (C). ***p ≤ 0.001.
dentate nucleus, Betz cells, and corticospinal tracts showed atro-
phy and degeneration. This is, however, in contrast to DRG,
which are the subject of hypoplasia and superimposed atrophy
(Koeppen and Mazurkiewicz, 2013). We propose that whereas
apoptotic cell death may be associated with neurodegeneration,
the senescent phenotype we observed could be a phenomenon
associated with hypoplasia and developmental delay, support-
ing the hypothesis proposed by Koeppen and Mazurkiewicz
(2013) that DRG are subject to hypoplasia and superimposed
atrophy.
The study in depth of and mitochondrial functions and
pathways such as bioenergetics and cellular redox status, has
established that frataxin deﬁciency causes mitochondrial failure.
In this paper we introduce new pathways and cellular processes
related to mitochondria biology, calcium homeostasis and ER
that have been related to neurodegeneration (Schon and Przed-
borski, 2011) but so far have not with FRDA pathogenesis.
Our data suggest that the lack of frataxin may induce cellular
senescence, changes in Ca2+ homeostasis and ER stress, which
participate in the generation of FRDA pathogenesis and neu-
ropathology. These mechanisms deserve additional exploration
as potential therapeutic targets for the treatment of FRDA
patients.
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